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Acute endotoxemia in rats induces down-regulation of V2 va-
sopressin receptors and aquaporin-2 content in the kidney
medulla.
Background. Endotoxemia can lead to fluid metabolism al-
terations despite unchanged or elevated plasma vasopressin
(VP) levels, suggesting a refractoriness of the kidney to the
effect of the peptide. To test this hypothesis, we examined the
effect of lipopolysaccharide (LPS) injection on the expression
of V2 receptors and aquaporin-2 in the kidney.
Methods. Plasma VP and urine osmolality, and binding of
[3H]VP to kidney membranes, Western blot, and immunohis-
tochemical analysis of aquaporin-2, in situ hybridization for
V2 VP receptors and cytokines mRNAs were measured in
the kidney 3 to 24 hours after LPS injection, 250 lg/100 g,
intraperitoneally.
Results. LPS injection caused prolonged decreases in urine
osmolality (up to 24 hours) without significant changes in
plasma levels of sodium or VP. This was associated with marked
decreases in V2 VP receptor mRNA and VP receptor number in
the kidney, which were evident for up to 12 hours after LPS in-
jection. Aquaporin-2 in kidney inner medulla was also reduced
by about 50%. LPS induced interleukin (IL)-1b in the kidney
medulla by 3 hours, reached maximum at 6 hours, and started to
decline by 12 hours, while it increased IL-6 mRNA significantly
only at 3 hours. Interleukin mRNA expression was absent in
kidneys of control rats. In vitro incubation of kidney medulla
slices with IL-1b reduced VP binding.
Conclusion. The inflammatory response to acute endotox-
emia down regulates V2 VP receptors and aquaporin-2 of the
kidney inner medulla resulting in prolonged impairment of the
renal capacity to concentrate urine.
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The systemic responses to endotoxin include fluid
metabolism and cardiovascular alterations, which in se-
vere circumstances can lead to water loss and hypoten-
sion [1, 2]. The mechanism of these alterations is likely to
be multifactorial, involving central and peripheral conse-
quences of the inflammatory reaction, including dysregu-
lation of hormones controlling blood pressure and water
conservation as well as local responses in organs such
as blood vessels and the kidney. The neuropeptide, va-
sopressin (VP), secreted into the systemic circulation by
axonal terminals from magnocellular hypothalamic neu-
rons in response to osmotic stimulation, is responsible for
water conservation in the kidney by acting upon VP (type
V2) receptors in the ascending loop of Henle and col-
lecting ducts [3]. The role of the vasopressinergic system
in hemodynamic alterations of endotoxemia is not com-
pletely understood. A number of investigators have ex-
amined the effects of lipopolysaccharide (LPS)-induced
endotoxemia on magnocellular neurons function, with
different studies showing either no effect, increases or
decreases in plasma VP and hypothalamic VP mRNA
levels [4–11]. Studies in our laboratory have shown small
but consistent decreases in VP mRNA in the paraven-
tricular nucleus (PVN) and supraoptic nucleus (SON)
and plasma VP 6 hours after injection of LPS in rats
[8, 11]. We have shown that VP responses to osmotic stim-
ulation are not only preserved but enhanced after LPS
administration, suggesting alterations of VP secretion are
not involved in the imbalance of water metabolism during
endotoxemia [9, 11]. In the absence of VP deficiency, an
alternative possibility is that endotoxemia causes impair-
ment of the renal actions of VP. A number of studies have
shown alterations in tubular function following LPS injec-
tion, such as decreases in glutamine reabsortion and uri-
nary ammonia excretion without changes in renal blood
flow [12]. LPS also decreases tubular secretion by reduc-
ing both the affinity and capacity of the tubular transport
system [13], and inhibits ion fluxes in the ascendant loop
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of Henle [14]. LPS-induced endotoxemia also decreases
renin expression in juxtaglomerular cells in mice, and ef-
fect that is mediated by transcriptional inhibition of renin
by cytokines [15].
The principal mechanism by which VP facilitates
water reabsortion in the kidney is by increasing the
content and membrane targeting of water channels or
aquaporins [16–19]. At least three aquaporins are present
in the collecting ducts of the kidney medulla (2, 3, and
4). While aquaporin-3 and 4 are constitutively expressed,
aquaporin-2 is the main effector of VP regulation. It is
possible that changes in aquaporin content in the renal
medulla are part of the mechanism contributing to renal
alterations during endotoxemia.
To determine the effects of endotoxemia on cytokine
expression in the kidney and on the renal responses to
VP, in these studies we examined the expression of the
proinflammatory cytokines, interleukin-1b (IL-1b) and
IL-6, V2 VP receptors, and aquaporin-2 in the inner
medulla of control and LPS-injected rats. The data show
that the inflammatory response to acute endotoxemia
leads to marked down-regulation of V2 VP receptor and
aquaporin-2 expression of the kidney inner medulla re-
sulting in prolonged impairment in the capacity of the
kidney to concentrate urine.
METHODS
Animals and treatments
Adult male Wistar rats were acclimated for at least
7 days in the animal facility (16 houraslight, 8 hours dark
cycle) with free access to food and water. Groups of four
to nine rats, three or fours per cage were assigned to
the two experimental groups: (1) controls (N = 7), re-
ceived ip injections of 300 lL of 0.9% saline; or (2) LPS
treated, received a single ip injection of LPS (from Es-
cherichia coli serotype 0111:B4, L-3012, Lot 36H4130)
(Sigma Chemical Co., St. Louis, MO, USA), 250 lg/100
g body weight, diluted in 300 lL of sterile saline. This
dose of LPS has been shown to elicit elevation of tem-
perature and diarrhea, accompanied by robust activation
of the hypothalamic-pituitary adrenal axis [4, 8]. Rats
were killed 3 hours (N = 4), 6 hours (N = 9), 12 hours
(N = 7), and 24 hours (N = 7) after LPS injection.
Rats were killed by decapitation and trunk blood col-
lected in ice-cold heparinized plastic tubes, the plasma
separated by centrifugation for 15 minutes at 4◦C for mea-
surement of VP and sodium concentrations. An aliquot of
urine was aspirated with a syringe from the urinary blad-
der immediately after decapitation. Kidneys were quickly
removed, frozen on dry ice and stored at −70◦C until sec-
tioning for in situ hybridization (one kidney from each rat,
N = 4) or Western blot (one kidney from each rat, N = 4).
Additional groups of rats were killed 6, 12, or 24 hours
after LPS injection (N = 3 per time point), the kidney
removed and collected in ice-cold phosphate-buffered
saline (PBS) for (3H(VP binding, or the kidney medulla
dissected and fixed in 4% paraformaldehyde and 0.4%
glutaraldehyde in PBS for immunohistochemical stain-
ing for aquaporin-2. All animal protocols were approved
by the NICHD ACUC.
Plasma VP, sodium, and urine osmolality
At the time of decapitation, trunk blood was collected
into chilled heparinized plastic tubes, centrifuged within
30 minutes (3,000 × g for 15 minutes at 4◦C) and the
plasma was stored at –70◦C. Samples were later thawed
for measurement of plasma Na+ concentration using an
ion-specific electrode analyzer (Beckman Elise Na/K/Cl
Analyzer) (Beckman, Brea, CA, USA), and plasma VP
by radioimmunoassay following acetone-ether extraction
as previously described [20]. The standard curve of the
arginine vasopressin (AVP) assay is linear between 0.5
and 10.0 pg/tube with the use of a synthetic VP standard
(Bachem Chemicals, Torrance CA, USA); minimum de-
tectable VP in extracted plasma is 0.5 pg/mL. The intra-
assay and interassay coefficients of variation reported for
previous studies are approximately 6.4% and 8.8%, re-
spectively. The VP antiserum used (R-4) displays com-
plete cross-reactivity with lysine vasopressin, but < 0.1%
cross-reactivity with oxytocin, arginine vasotocin, and
desmopressin [20]. Using this assay, basal levels of VP
in the plasma of normal conscious rats range from 0.5
to 3.0 pg/mL with increases to 15 to 80 pg/mL follow-
ing acute osmotic stimulation with hypertonic (2 mol/L)
NaCl [21]. Urine osmolality was measured in an Osmo-
mat 010 (Gonotec Medizintecknik, Berlin, Germany).
Vasopressin binding
Kidneys were bisected on ice and the inner medulla and
papilla dissected with sharp scissors. VP receptors were
measured by binding of [3H]VP to 30,000 × g membrane
fractions prepared from pools of three kidney medullas
as previously described [22]. Binding affinity and recep-
tor concentration were calculated by Scatchard analysis
using the computer program Ligand [23].
In situ hybridization
Cryostat sections, 12 lm thick, were mounted in poly-
lysine coated slides and stored in a –70◦C freezer until
processed for in situ hybridization. The V2 VP recep-
tor probe was a 745 bp cDNA fragment cloned into
the EcoR1 site of pcDNA1, provided by Dr Stephen
Lolait, NIMH, NIH. A rat IL-1b probe corresponding
to bases 380 to 930 and a rat IL-6 probe corresponding
to bases 34 to 570, both cloned into pGEM-5zf(+) at the
EcoR-V site, were obtained from the concerted Action
Program for the European Community, Dr R Dantzer,
Project Leader, INSERM, Bordeaux, France.
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Prehybridization and hybridization procedures were
performed as previously described [24]. Briefly, prior to
hybridization, sections were thawed at room tempera-
ture, fixed in 4% formaldehyde in PBS for 5 minutes
at room temperature, washed three times with PBS, and
acetylated for 10 minutes at room temperature in 0.25%
acetic anhydride in 0.1 mol/L triethanolamine/0.9% NaCl
(pH 8.0). Sections were dehydrated and defatted by se-
quential transfer through ethanol and chloroform and air-
dried. Sections were hybridized at 55◦C overnight with
1 to 2 × 106 cpm 35-S–labeled probe, and then non-
hybridized probe was removed by washing in 50% for-
mamide/250 mmol/L NaCl at 60◦C for 10 to 15 minutes,
followed by ribonuclease A treatment for 30 minutes at
37◦C and three washes in 0.1 × standard sodium citrate
(SSC) at 60◦C for 15 minutes.
For semiquantification of hybridization signals, sec-
tions were exposed to the highly sensitive autoradiog-
raphy film BIOMAX MR (Kodak, IBI, New Haven, CT,
USA) for the appropriate periods of time (7 days for V2
VP receptor mRNA and 30 days for IL-1b and IL-6).
Exposure times were considered adequate when the op-
tical density readings of the sections were within the
semilinear portion of the readings of 14C-labeled stan-
dards (American Radiochemical, St. Louis MO, USA).
Light transmittance of autoradiographic film images was
measured by computerized image analysis (Imaging Re-
search, St. Catherine, Ontario, Canada), using the pub-
lic domain NIH Image program (developed at the US
National Institutes of Health, and available at the Inter-
net at http://rsb.Info.nih.gov/nih-image). Results are pre-
sented as the mean and SEM of integrated density values
(transmittance × area).
Aquaporin-2 Western blot analysis
Kidneys were immediately removed, bisected, and the
inner medulla dissected and homogenized in ice-cold
isolation solution (250 mmol/L sucrose, 10 mmol/L tri-
ethanolamine, pH 7.6, containing 1 mg/mL leupeptin, 0.1
mg/mL phenylmethylsulphonyl fluoride) using a tissue
homogenizer (Omni 1000 fitted with a micro-sawtooth
generator) at maximum speed for three 15-second inter-
vals. Total protein concentrations were measured (BCA
Kit) (Pierce Chemical Co., Rockford, IL, USA) and the
samples were solubilized in Laemmli sample buffer at
60◦C for 15 minutes. Semiquantitative immunoblotting
was carried out as previously described [25, 26]. To
equalize protein loading of the gels, preliminary 12%
polyacrylamide gels were stained with Coomassie blue
as previously described [27] and densitometry of major
bands was performed. For immunoblotting, sodium
dodecyl sulfate-polyacrylamide gel electophoresis
(SDS-PAGE) was performed on 7.5%, 10% or 12%
polyacrylamide gels (Ready Gels) (Bio-Rad, Hercules,
CA, USA). The proteins were transferred electrophoret-
ically (Mini Trans-Blot Cell) (Bio-Rad) to nitrocellulose
membranes (Bio-Rad). Membranes were blocked for
1 hour at room temperature with 5% nonfat dry milk
and probed overnight at 4◦C with the appropriate
affinity purified antibodies. Membranes were washed
and exposed to one of the following horseradish
peroxidase-labeled secondary antibodies for 1 hour
at room temperature: rabbit antisheep IgG (Zymed
Laboratories, Inc., No. 81-8620, San Francisco, CA,
USA) (diluted 1:5000), goat antirabbit IgG (Pierce
Chemical Co., No. 31463) (diluted to 1:5000) or rabbit
antimouse IgG (Pierce Chemical Co., No. 31450) (di-
luted 1:5000). After washing, sites of antibody-antigen
reaction were visualized using a luminol-based enhanced
chemiluminescence substrate (LumiGLO, Kirkegaard
and Perry Laboratories, Gaithersburg, MD, USA) before
exposure to light-sensitive film (Kodak, No. 165-1579).
Light transmittance of the bands was evaluated by
computerized image analysis using the software NIH
Image, as described for in situ hybridization.
Aquaporin-2 immunohistochemistry
Inner medulla from kidneys of controls and
LPS-injected rats (6 hours) were dissected and fixed in
4% paraformaldehyde on PBS, pH 7.8, for 5 days at 4◦C,
and embedded in epoxy resin using routine procedures.
For light microscopy, semithin sections (1 lm) were
cut in an ultratome and mounted on Poly-L–coated
slides. Sections were encircled with a diamond pen,
the epoxy resin was removed with methanol-NaOH,
methanol-benzol solution followed by acetone, and
rehydrated in PBS (pH 7.8). Sections were incubated
overnight at 4◦C with affinity-purified antiaquaporin-2
antibody (LL127AP) [28] at a dilution of 1:1000, an then
washed in PBS (3 × 10 minutes), at room temperature,
and incubated with an antirabbit second antibody (poly-
clonal IgG, 1:100) (Sigma Chemical Co.) for 30 minutes
at room temperature. After 3 × 10 minute washes in
PBS, sections were incubated for 30 minutes at room
temperature with peroxidase-anti-peroxidase (PAP)
complex, and washed in PBS (3 × 10 min at room
temperature). Aquaporin-2-IgG-PAP complexes were
developed in diamidinobenzidine (DAB) for 10 minutes
at room temperature, and the sections dehydrated and
coverslipped. Control sections were incubated with
bovine serum albumin (BSA) instead of primary anti-
body. Stained sections were examined under an Olympus
BX50 microscope with a digital camera Olympus PC10.
In vitro effect of IL-1 on VP binding in kidney medulla
To determine the effects of direct effect of cytokines
on VP binding, kidney medullas were incubated in vitro
with IL-1b before measurement of VP binding. Kidneys
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Table 1. Effect of lipopolysaccharide (LPS)-induced endotoxemia on
plasma vasopressin (VP) and sodium levels, and urine osmolality
LPS LPS LPS
Basal 3 hours 6 hours 12 hours
Plasma vasopressin 2.8 ± 1.1 2.3 ± 1.3 1.4 ± 0.3 1.6 ± 0.5
pg/mL
Plasma sodium 144 ± 3 138 ± 3 145 ± 2.8 138 ± 3.1
mEq/L
Urine osmolality 2210 ± 283 774 ± 87a 1292 ± 152a 1036 ± 152a
mOsm/L
Rats received a single injection of LPS (250 lg/100 g) and killed by decapitation
at the indicated times.
aP < 0.001 vs. basal.
were bisected sagitally, each half was placed on top of a
Petri dish with ice and with a microtome blade an approx-
imately 1 mm slice containing the medulla was taken with
a microtome blade while pressing the tissue against the
Petri dish with a glass slide. After removal of the cortex,
medullas from each kidney half were placed into oppo-
site wells of 6-well plates containing 2 mL of Dulbecco’s
minimal essential medium (DMEM) (Invitrogen, Carls-
bad, CA, USA) with 0.1% BSA. Tissue from two rats
per well (four slices) were preincubated for 30 minutew
in a water bath at 37◦C, under 95% O2/5%CO2, before
addition of vehicle or IL-1 b 0.1 ug/mL, and incubation
for an additional 6 hourw. At the end of the incubation
tissue from three wells (12 slices) was homogenized in ice
cold, 20 mmol/L sodium bicarbonate, for preparation of
30,000g membrane fractions [22].
RESULTS
Effect of LPS on plasma VP, sodium, and urine osmolality
Injection of the bacterial endotoxin, LPS, 250 lg/100 g,
intraperitoneally, caused rapid and marked decreases in
urine osmolality. Levels decreased by 65% after 3 hours
and remained at levels below 50% the controls 24 hours
after LPS injection (Table 1). Despite the decrease in
urine osmolality, plasma sodium levels remained at lev-
els similar to controls up to 12 hours. Plasma VP lev-
els showed a tendency to decrease by 6 and 12 hours
but levels were not significantly different from controls
(Table 1).
Effect of LPS on V2 VP receptors
To determine whether alterations in VP receptors are
involved in the impaired capacity of the kidney to con-
centrate urine, we measured V2 VP receptor mRNA and
VP binding in the kidney inner medulla. Scatchard anal-
ysis of the binding of [3H]VP to kidney inner medulla
membranes revealed marked reductions in the number
of binding sites from a control value of 592 ± 12 arbitrary
units to 254.7 ± 17 arbitrary units, 235.4 ± 11 arbitrary
units, and 324 ± 18 arbitrary units, following 6, 12, and
24 hours of LPS injection (P < 0.01 controls vs LPS at
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Fig. 1. Scatchard analysis of the binding of [3H] vasopressin (VP) to
inner medulla kidney membranes from control rats and 6, 12, and
24 hours after a single lipopolysaccharide (LPS) injection, 250 lg/
100 g. Data points are the mean of duplicate incubations in one of three
experiments. There is the marked decrease in the number of binding
sites 6, 12, and 24 hours following LPS injection without changes in bind-
ing affinity. Binding affinities (kDd) for the mean of three experiments
is shown in the inset.
all time points, N = 3). No significant changes in binding
affinity were observed at any of the time points measured
(Fig. 1). The decreases in VP binding were associated with
decreases in V2 VP receptor mRNA. In situ hybridization
studies showed V2 VP mRNA hybridization with the ex-
pected localization in the inner medulla (Fig. 2A). V2 VP
mRNA levels decreased markedly by 3 and 6 hours and
started to recover by 12 hours. Integrated density values
decreased more than 90% by 3 and 6 hours (P < 0.001)
after LPS injection and had returned to about 50% the
control levels by 12 hours (Fig. 2B). Values at 24 hours
were significantly higher than at 6 hours but still lower
than controls.
Effect of LPS on aquaporin-2 in the inner medulla
The downregulation of VP receptors in kidney inner
medulla of rats injected with LPS were accompanied by
decreases in aquaporin-2 content of the inner medulla.
Semiquantitative Western blot analysis two bands of 36
to 45 kD and 29 kD corresponding to the expected molec-
ular size of glycosylated and nonglycosylated forms of
aquaporin-2 (Fig. 3A). The higher molecular weight band
decreased from 66.7 ± 7.7 arbitrary units to 38.3 ± 4.6 ar-
bitrary units, 37.3 ± 3.8 arbitrary units, and 29.0 ± 5.7
arbitrary units at 6, 12, and 24 hours after LPS injection,
respectively. The lower molecular weight band decreased
from 100.7 ± 8.3 arbitrary units to 40.3 ± 8.3 arbitrary
units, 49.0 ± 2.3 arbitrary units, and 55.7 ± 8.8 arbitrary
units after 6, 12, and 24 hours of LPS injection, respec-
tively (Fig. 3B).
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Fig. 2. Effect of lipopolysaccharide (LPS) injection on V2 vasopressin
(VP) receptor mRNA levels. (A) Representative images of film autora-
diography of in situ hybridization for VP V2 receptor mRNA in kidney
sections from saline injected control rats (LPS 0 hours), and rats sub-
jected to a single LPS injection 3, 6, or 12 hours before sacrifice. (B)
Semiquantitative analysis of VP V2 mRNA levels. Data points are the
mean and SE of data obtained in four rats per experimental group. ∗P <
0.01 vs. vehicle injected control (0 hours); #,P < 0.05 vs. 6 hours. Abbre-
viations are: IM, inner medulla; OM, inner stripe of the outer medulla;
P, papilla; V2-R, vasopressin type 2 receptor.
Immunohistochemical analysis revealed marked
aquaporin-2 immunostaining in the apical membrane of
collecting duct cells of control rats (Fig. 4). Confirming
the Western blot results, there was a clear decrease in
aquaporin-2 immunostaining in the kidney medulla of
rats receiving LPS injection 6 hours earlier (Fig. 4) How-
ever, the predominance of apical labeling persisted (i.e.,
there was not evidence for aquaporin-2 internalization).
Effect of LPS on IL-1b and IL-6 expression in the kidney
There was no detectable hybridization for IL-1b or
IL-6 mRNAs in kidney sections of control rats. Induction
of mRNA for both cytokines with preferential location
in the inner medulla was observed after LPS injection
(Figs. 5). IL-1b mRNA was detectable at 3 hours, al-
though levels were not significantly different from con-
trols. IL-1b mRNA levels reached maximum at 6 hours
and remained elevated up to 12 hours, the last time point
measured (Fig. 5, upper panels, and Fig. 6A).
Expression of IL-6 mRNA, was found in the inner
medulla by 3 hours after LPS injection (P < 0.005)
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Fig. 3. Western blot analysis of the changes in aquaporin-2 protein in
the inner medulla of kidneys from saline injected control rats and rats
subjected to a single ip injection of lipopolysaccharide (LPS) 6, 12, and
24 hours before sacrifice. (A) Representative immunoblots in three rats
per group revealing two immuoreactive bands of 29 kD and 36 to 45 kD,
corresponding to nonglycosylated and glycosylated forms of aquaporin-
2, respectively. (B) Semiquantitative analysis of aquaporin-2 bands in
four rats per experimental group. ∗P < 0.05 vs. vehicle-injected controls.
and returned to almost undetectable levels by 6 and
12 hours (Fig. 5, bottom panels, and Fig. 6B). In addi-
tion to the inner medulla, very low levels of diffuse IL-6
mRNA hybridization were observed throughout the re-
nal parenchima (Fig. 5, bottom panels).
Direct effect of cytokines on VP binding
In two separate experiments using triplicate incuba-
tions, Scatchard analysis of the binding data of mem-
brane fractions from bisected kidney medullas revealed a
53% ± 7.1% (P < 0.02, N = 2), decrease in the binding of
[3H]VP after 6 hours incubation with 0.1 lg IL-1b com-
pared with control incubations (316 ± 17 fmol/mg and
146 ± 15 fmol/mg, respectively).
DISCUSSION
These studies show the decreases in urine osmolal-
ity a marked down-regulation of V2 VP receptors and
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Fig. 4. Light microscopy analysis of aquaporin-2-immunoreactivity in
semithin sections of kidney medulla of a control rat (A) and 6 hours
after lipopolysaccharide (LPS) injection (B). LPS injection (B) leads
to a profound decrease in intensity of aquaporin-2 staining in apical
membranes of medullar collecting duct cells (arrows) (magnification ×
40).
aquaporin-2 in the kidney inner medulla following a sin-
gle LPS injection, and suggest that an impairment of
VP action contribute to alterations in fluid metabolism
during endotoxemia. The renal effects of LPS are com-
plex and in addition to the V2 VP receptor and aqua-
porin down-regulation are likely to involve additional
hemodynamic and ion transport alterations. Based on the
decreases in V2 receptors and aquaporin-2, one would
expect an increased urinary volume associated with the
reduced urinary osmolality. Urinary output was not
measured in the present experiments but it has been
reported that LPS administration decreases rather than
increases urinary output as a consequence of a decrease
in glomerular blood flow [29] and glomerular flow rate
[10]. In the above reports and in previous studies of
this laboratory using the present experimental condi-
tions [11], systemic blood pressure was unchanged after
LPS injection, suggesting that decreased glomerular per-
fusion must be the result of regional changes in blood
flow. In addition, it has been shown that intravenous in-
fusion of higher doses of LPS increases the expression
of sodium/potassium/chloride cotransporter in the kid-
ney medulla [10]. It is not known whether LPS increased
cotransporter levels in the present experimental condi-
tions, but this could contribute to the decrease in urine
osmolality by increasing sodium reabsortion [10]. The de-
creases in glomerular filtration rate and increases in co-
transporter reported after LPS administration [10, 29]
could at least in part explain the lack of polyuria in pres-
ence of a down-regulation of V2 receptors and aquaporin-
2 in the kidney medulla.
A major target for regulation of collecting duct perme-
ability by VP is the apical water channel, aquaporin-2.
VP increases the expression, phosphorylarion, and traf-
ficking of aquaporin-2 [3, 19, 30]. In the present exper-
iments, down-regulation of V2 VP receptors paralleled
a reduction in the content of aquaporin-2 protein, as
shown by both Western blot and immunohistochemistry.
Since a major factor regulating aquaporin content in the
kidney is VP, it is likely that the decrease in V2 vaso-
pressin receptors expression and content in the kidney
medulla is part of the mechanism responsible for the
decrease in aquaporin-2 protein observed after LPS in-
jection in the present experiments. Similar parallel re-
ductions in VP binding in the kidney [27, 31] and aqua-
porin expression have been described during renal escape
from VP-induced diuresis. In keeping with the rapid loss
in aquaporin-2 protein following LPS injection, studies
in transfected cells have show that the half-life of aqua-
porin in the cell is relatively short, 4 hours [32]. In con-
trast to the present findings, Jonassen et al [10] showed
marked elevations in plasma VP levels and no change in
aquaporin-2 content in the kidney following iv infusion
of a much higher dose of LPS (4 mg/kg over 1 hour).
While the differences in plasma VP responses to LPS in
these studies could be the result of diverse experimen-
tal conditions, the marked increases in circulating VP in
the later study would be expected to cause up-regulation
of aquaporin-2 content in the kidney. Thus, the lack of
the expected increase in aquaporin-2 levels may reflect
an altered vasopressinergic regulation in the kidney. This
would be consistent with the proposal that the effect
of VP on water conservation is impaired during LPS-
induced endotoxemia, and that this effect is mediated
by a decrease in V2 VP receptors in the kidney medulla
as shown in this study.
While the decrease in aquaporin expression is likely
to be the consequence of the V2 receptor loss following
LPS injection, an important remaining question is the
mechanism of the V2 receptor down-regulation. Con-
sistent with the recognized ability of endotoxins to in-
duce proinflammatory cytokines, LPS injection caused
rapid induction of IL-1b and IL-6 in the kidney, and the
predominant site of expression was the renal medulla.
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Fig. 5. Film autoradiography images illus-
trating hybridization for interleukin-1b (IL-
1b) and IL-6 mRNA in the kidney of saline
injected control rats (0 hours), and rats sub-
jected to a single ip lipopolysaccharide (LPS)
injection 3, 6, and 12 hours before sacrifice.
Images are representative of findings in four
rats per experimental group.
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Fig. 6. Semiquantitative analysis of interleukin-1b (IL-1b) (A) and IL-6
(B) mRNAs from film images obtained by in situ hybridization in kidney
sections from saline-injected controls and rats subjected to a single
lipopolysaccharide (LPS) injection 3, 6, and 12 hours before sacrifice.
Data points are the mean and SE of the values in four rats per group.
∗P < 0.01 vs controls.
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Fig. 7. Scatchard analysis of the binding of [3H] vasopressin (VP) to
membrane fractions prepared from pools of 3 pairs of bisected kidney
medullas following in vitro incubation in the absence and presence of
0.1 lg/mL interleukin-1b (IL-1b). Data points are the mean of duplicate
incubations in one of two experiments. IL-1b caused a significant de-
crease in VP binding sites compared with control incubations, without
changes in affinity (mean and SE in two experiments is shown in the
inset).
Cytokines play an important role in mechanisms that de-
press renal function in response to inflammatory diseases
of the kidney [14, 33, 34]. The present demonstration
that IL-1b was able to reduce the number of VP recep-
tors in kidney medullas in vitro strongly suggests that the
local increase in cytokine expression is involved in the
alterations of V2 VP receptors observed following LPS
injection. The inflammatory actions of cytokines could
be at least partially mediated through induction of ni-
tric oxide synthase and cyclooxygenase and consequent
production of nitric oxide and prostaglandins [35–37].
In situ hybridization studies in rats have shown marked
induction of cyclooxygenase-2 mRNA in the kidney
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inner medulla from undetectable levels following LPS
injection [38]. In this regard, while in normal conditions
the medullary thick ascending limb of Henle’s loop of
the nephron generates 20-hydroxyeicosatetraenoic acid
(20-HETE) through the lipooxygenase pathway, follow-
ing LPS injection, arachidonic acid metabolism is di-
rected to the cyclooxygenase pathway with generation of
prostaglandins [39]. Both prostaglandins and nitric oxide
have been implicated in the pathogenesis of organ dis-
function observed during endotoxemia [33, 40–42], and
they could play a role in the renal effects of LPS described
in these studies.
Similar to the present observations with the V2 VP
receptors, LPS-induced endotoxemia has been reported
to induce down-regulation of other G-protein coupled re-
ceptors such as V1a vasopressin [43], type 1 angiotensin II
(AT1) [44] and alpha-adrenergic receptors [45, 46]. These
decreases in receptors were associated to decreased pres-
sor responses to the ligands. Similar to the present exper-
iments, the later reports show that cytokines can induce
receptor downregulation in cultured messangial cells or
hepatocytes in vitro. This effect was dependent on nitric
oxide production for type 1 angiotensin II receptors in
messangial cells [44], while the reduction in a-adrenergic
and V1a vasopressin receptors was nitric oxide indepen-
dent [43, 46]. The receptor down-regulation observed in
the present study and former reports is unlikely to re-
flect a general inhibitory effect due to non-specific mem-
brane alterations, since LPS injection has been shown to
increase renal endothelin receptors [47, 48].
The decrease in immunoreactive aquaporin is likely
to involve transcriptional and posttranscriptional events
mediated by decreased effectiveness of VP and other
consequences of the inflammatory process [41, 49]. The
Western blot and immunohistochemistry show a clear de-
crease in aquaporin protein content in the membrane and
cytosolic compartments. While VP increases aquaporin-
2 mRNA and protein, administration of the non-peptide
V2 receptor antagonist, OPC-31260, causes the oppo-
site effect [30]. Thus, it is likely that decreased effec-
tiveness of VP due to V2 receptor loss contributes to
the donwregulation of aquaporin-2 following LPS injec-
tion. In addition, increases in renal production of nitric
oxide and prostaglandins as result of the increase in cy-
tokines may play a role decreasing renal aquaporin-2,
directly or as a result of the downregulation of V2 VP
receptors. In this regard, studies using nitric oxide syn-
thetase and cyclooxygenase inhibitors have shown that
nitric oxide and prostaglandin play important roles in
the down-regulation of aquaporin-2 associated with es-
cape from VP-induced antidiuresis [42]. In addition, it
has been shown that the inflammation inhibitor alpha-
melanocyte-stimulating hormone (MSH) blocks the de-
creases in aquaporin associated with acute renal failure
induced by ischemia or urinary tract obstruction [50].
CONCLUSION
LPS-induced endotoxemia leads to long-term de-
creases in urinary osmolality parallel to marked down-
regulation of V2 VP receptors and aquaporin-2 of the
kidney inner medulla in the presence of normal plasma
VP levels. This is probably the result of local inflamma-
tory responses as indicated by the induction of cytokine
expression in the renal medulla and the ability of IL-1b
to down-regulate VP receptors in vitro. The data suggest
that a decreased renal capacity to concentrate urine due
to an impairment of VP action in the kidney contributes
to disturbances of fluid homeostasis during endotoxemia.
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